Role of Microenvironment in Resistance to Therapy in AML
about
The Hematopoietic Niche in Myeloproliferative NeoplasmsMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentMicroRNA-9 plays a role in interleukin-10-mediated expression of E-cadherin in acute myelogenous leukemia cellsHIF-1α inhibition by 2-methoxyestradiol induces cell death via activation of the mitochondrial apoptotic pathway in acute myeloid leukemia.Modeling the Pro-inflammatory Tumor Microenvironment in Acute Lymphoblastic Leukemia Predicts a Breakdown of Hematopoietic-Mesenchymal Communication NetworksThe Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.Pro-inflammatory-Related Loss of CXCL12 Niche Promotes Acute Lymphoblastic Leukemic Progression at the Expense of Normal Lymphopoiesis.The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signalingA phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia.Targeting of cell metabolism in human acute myeloid leukemia--more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling?Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC.Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma.Predicting Chemotherapy Resistance in AML.CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine.Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia.Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming.Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins.Cytarabine and daunorubicin for the treatment of acute myeloid leukemia.Alginate foam-based three-dimensional culture to investigate drug sensitivity in primary leukaemia cells.Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trial.Complete Remission of a Refractory Acute Myeloid Leukemia with Myelodysplastic- and Monosomy 7-Related Changes after a Combined Conditioning Regimen of Plerixafor, Cytarabine and Melphalan in a 4-Year-Old Boy: A Case Report and Review of Literature
P2860
Q26773192-41978810-C5AA-4296-B6A7-382E2D779028Q28073613-DC21A455-62BD-4C0E-819A-1BE01866AA7AQ33607590-C10AC2A9-7211-4894-B21E-CDF4622D9212Q37187783-8F447B42-4435-417C-B704-3F5DE25EF35AQ37188090-4C19F555-08F3-4E98-ABD6-0D6B76CE5497Q37526352-0397C50B-7B0C-4C81-B99C-C18E14109F68Q37564113-751195DA-65E9-4908-8AEE-F51EC5ED2EA8Q37709259-1CCA31D0-5BE5-48F0-A4CF-D9B6083FB255Q37737798-F0B5D9DC-8B8F-4942-BAEC-4E3CF3DF8D06Q38606849-B2413C27-FECB-4ED3-9BD6-C0E609DB88BBQ38610677-B48B443D-33BD-4093-95C8-AE748A63CF62Q38947056-BDF9137B-BABE-4246-9D5D-F8B29A0B4BC0Q39233284-130F3FAD-E01D-4E9B-A721-8F76B3FF2845Q40118769-E2F42A42-718C-438F-9614-95073EAB99FCQ41004145-C28C1323-CE6D-456E-9DDB-BBAE80596E06Q41867996-0EA3BBFC-6160-458E-8684-78F49189A87AQ47235352-51A9A57A-6FD7-4B22-ABAA-466C753D7120Q50090381-9A12C105-EA9D-45C4-88D6-3CF6DBB1ED6EQ52562901-F5CF22A5-DB80-45D9-912C-EAD20AB22E98Q54109032-A5170C89-5447-460A-AEC4-E8AA3D6318F8Q58700173-ACFCAC3D-173A-4CBB-89D4-34689B8B554D
P2860
Role of Microenvironment in Resistance to Therapy in AML
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Role of Microenvironment in Resistance to Therapy in AML
@ast
Role of Microenvironment in Resistance to Therapy in AML
@en
Role of Microenvironment in Resistance to Therapy in AML
@nl
type
label
Role of Microenvironment in Resistance to Therapy in AML
@ast
Role of Microenvironment in Resistance to Therapy in AML
@en
Role of Microenvironment in Resistance to Therapy in AML
@nl
prefLabel
Role of Microenvironment in Resistance to Therapy in AML
@ast
Role of Microenvironment in Resistance to Therapy in AML
@en
Role of Microenvironment in Resistance to Therapy in AML
@nl
P2860
P3181
P1476
Role of Microenvironment in Resistance to Therapy in AML
@en
P2093
P2860
P2888
P304
P3181
P356
10.1007/S11899-015-0253-6
P407
P577
2015-06-01T00:00:00Z
P6179
1048985682